Adalimumab 83012-0011-10
- Manufacturer
- Boehringer Ingelheim Fremont, Inc.
- Dosage Form
- Liquid
- Product Type
- Drug For Further Processing
- Marketing Start
- April 30, 2024
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Adalimumab-Adbm | 40 mg/.4mL |
Selected Package
83012-0011-10Selected1 mL in 1 SYRINGE (83012-011-10)